Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 517

1.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.

Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, Sarpel U, Labow DM.

J Gastrointest Surg. 2014 May;18(5):1024-31. doi: 10.1007/s11605-014-2477-5. Epub 2014 Feb 28.

PMID:
24577736
2.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.

Iversen LH, Rasmussen PC, Hagemann-Madsen R, Laurberg S.

Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.

PMID:
23458368
3.

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.

Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.

Eur J Surg Oncol. 2013 Nov;39(11):1207-13. doi: 10.1016/j.ejso.2013.08.017. Epub 2013 Sep 2.

PMID:
24007834
4.

Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.

Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.

PMID:
25145504
5.

[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin].

Berger Y, Zbar AP, Lebedyev A, Levi Y, Nevler A, Aderka D, Golan T, Purim O, Brenner B, Natur M, Gutman M.

Harefuah. 2014 Jun;153(6):315-9, 368. Hebrew.

PMID:
25095601
6.

Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.

Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.

J Surg Oncol. 2013 May;107(6):585-90. doi: 10.1002/jso.23303. Epub 2012 Dec 27.

PMID:
23280508
7.

Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly.

Tabrizian P, Jibara G, Shrager B, Franssen B, Yang MJ, Sarpel U, Hiotis S, Labow D.

Surg Oncol. 2013 Sep;22(3):184-9. doi: 10.1016/j.suronc.2013.06.001. Epub 2013 Jul 1. Review.

8.

Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.

Marcotte E, Dubé P, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Sideris L.

World J Surg Oncol. 2014 Nov 7;12:332. doi: 10.1186/1477-7819-12-332.

9.

Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.

Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ.

Eur J Surg Oncol. 2015 Mar;41(3):396-9. doi: 10.1016/j.ejso.2014.08.476. Epub 2014 Sep 2.

PMID:
25216980
10.

Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients.

Passot G, Bakrin N, Roux AS, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

Eur J Surg Oncol. 2014 May;40(5):529-35. doi: 10.1016/j.ejso.2013.11.019. Epub 2013 Dec 14.

PMID:
24370285
11.

Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, Aydin N, Gushchin V.

Ann Surg Oncol. 2014 Dec;21(13):4218-25. doi: 10.1245/s10434-014-3869-1. Epub 2014 Jul 2.

PMID:
24986239
12.

Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.

Wong JF, Tan GH, Wang W, Soo KC, Teo MC.

World J Surg. 2015 Jun;39(6):1578-83. doi: 10.1007/s00268-015-2986-8.

PMID:
25651962
13.

Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.

Chua TC, Quinn LE, Zhao J, Morris DL.

J Surg Oncol. 2013 Aug;108(2):81-8. doi: 10.1002/jso.23356. Epub 2013 Jun 5.

PMID:
23737041
14.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
15.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.

Teo MC, Tan GH, Tham CK, Lim C, Soo KC.

Ann Surg Oncol. 2013 Sep;20(9):2968-74. doi: 10.1245/s10434-013-2947-0. Epub 2013 Mar 17.

PMID:
23504144
16.

Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution.

Akaishi E, Teixeira F, Katayama M, Mizumoto N, Costa FP, Buzaid AC, Hoff PM.

World J Surg. 2009 Apr;33(4):835-9; discussion 840. doi: 10.1007/s00268-008-9880-6.

PMID:
19169741
17.

The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.

El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A.

Ann Surg Oncol. 2012 Jan;19(1):110-4. doi: 10.1245/s10434-011-1840-y. Epub 2011 Jun 24.

PMID:
21701929
18.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL.

J Clin Oncol. 2012 Jul 10;30(20):2449-56. doi: 10.1200/JCO.2011.39.7166. Epub 2012 May 21.

19.
20.

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.

Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.

Ann Surg Oncol. 2009 Feb;16(2):345-51. doi: 10.1245/s10434-008-0226-2. Epub 2008 Nov 19.

PMID:
19018599
Items per page

Supplemental Content

Write to the Help Desk